anthranilamide has been researched along with adenine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barril, X; Borgognoni, J; Brough, PA; Chene, P; Davies, NG; Davis, B; Drysdale, MJ; Dymock, B; Eccles, SA; Fromont, C; Garcia-Echeverria, C; Hayes, A; Hubbard, RE; Jensen, MR; Jordan, AM; Massey, A; Merrett, A; Padfield, A; Parsons, R; Radimerski, T; Raynaud, FI; Robertson, A; Roughley, SD; Schoepfer, J; Sharp, SY; Simmonite, H; Surgenor, A; Valenti, M; Walls, S; Webb, P; Wood, M; Workman, P; Wright, L | 1 |
1 other study(ies) available for anthranilamide and adenine
| Article | Year |
|---|---|
Combining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperone.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Binding, Competitive; Crystallography, X-Ray; Female; Fluorescence Polarization; HSP90 Heat-Shock Proteins; Humans; Male; Mice; Mice, Inbred BALB C; Pyrimidines; Xenograft Model Antitumor Assays | 2009 |